Memorial Sloan Kettering physician-scientist Ross Levine

Ross L. Levine, MD

Leukemia Specialist & Physician-Scientist

Areas of Expertise

Conditions I Treat

  • Blood, bone marrow, and hematologic cancers and conditions
  • Leukemia
  • Myeloproliferative neoplasms (MPN)/Myeloproliferative disorders

My Specialties

  • Clinical trials
  • Targeted therapy
  • Biopsy
View more expertise
Dr. Levine's Office Information
Languages: English
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.

Get to Know Me

I am a physician-scientist focused on researching and treating blood and bone marrow cancers, including acute myeloid leukemia and the chronic myeloproliferative neoplasms polycythemia vera, essential thrombocytosis, and primary myelofibrosis.

Taking care of people with leukemia during my residency and fellowship inspired my interest in the disease. I saw that while our treatments could be quite effective the first go-round, many leukemia patients relapse. That got me thinking about how we could better understand why leukemia develops and how we could create new, targeted treatments to improve outcomes.

When I am not running my research lab (more information on that here), I treat people with leukemia on an inpatient basis. I do approximately 30 procedures a year, most of which are bone marrow biopsies.

Most people feel overwhelmed when they are first diagnosed, so our job is to give them the information they need and to show them that a whole team of experts is here to help them through the process. My hope is that patients leave our interactions feeling empowered and hopeful.

Outside of work, I love spending time with my family, playing tennis and squash, and rooting for the New York Mets!

What I Do at MSK

I’m a leukemia specialist, which is a doctor with special training in diagnosing and treating leukemia (loo-KEE-mee-uh). This cancer starts in tissue that forms blood, such as bone marrow.

I'm a physician-scientist, which is a doctor who also is a researcher.

  • Chief Scientific Officer
  • Edward P. Evans Endowed Chair for Myelodysplastic Syndromes (MDS) at MSK
Areas of Expertise

Conditions I Treat

  • Blood, bone marrow, and hematologic cancers and conditions
  • Leukemia
  • Myeloproliferative neoplasms (MPN)/Myeloproliferative disorders
  • Acute myeloid leukemia (AML)
  • Polycythemia vera
  • Myelofibrosis
  • Clonal hematopoiesis (CH)

My Specialties

  • Clinical trials
  • Targeted therapy
  • Biopsy
Education & Honors

Education

  • MD, Johns Hopkins University School of Medicine

Residencies

  • Internal Medicine - Massachusetts General Hospital

Fellowships

  • Hematology/Medical Oncology - Dana Farber Cancer Institute/Partners Cancer Care

Board Certifications

  • Internal Medicine
  • Hematology
  • Medical Oncology

Awards and Honors

  • Outstanding Investigations Award, National Cancer Institute (2023)
  • Excellence in Scientific Service Award, Leukemia & Lymphoma Society (2023)
  • Pershing Square Sohn Prize for Cancer Research (2014)
  • Laurence Joseph Dineen Chair in Leukemia Research (2013)
  • Leukemia and Lymphoma Society Scholar (2012)
  • Boyer Award for Clinical Research
  • Memorial Sloan Kettering Cancer Center (2011)
  • Howard Hughes Medical Institute Early Career Award (2007)
  • American Society of Hematology Basic Research Fellow Award (2006)
  • American Society of Clinical Oncology Young Investigator Award (2006)
  • American Society of Hematology 2016 Scientific Program co-chair Medical and Scientific Advisory Board, Leukemia and Lymphoma Society

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Women talking
New Patients
Scheduling an appointment is easy. Click or call 646-497-9154— we’re available 24 hours a day, 7 days a week
Make an Appointment
Current Patients
Request an appointment by calling your Care Team or messaging them in MSK MyChart.

Contact and Location

Office Phone
Location
New York, NY
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
530 East 74th Street New York NY 10021
Get Directions

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Leukemia Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

View Dr. Levine's Lab

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Ross L. Levine discloses the following relationships and financial interests:

  • Ajax Therapeutics, Inc.
    Equity; Fiduciary Role / Position; Intellectual Property Rights; Professional Services and Activities (Uncompensated)
  • Auron Therapeutics, Inc.
    Equity; Professional Services and Activities (Uncompensated)
  • C4 Therapeutics
    Professional Services and Activities
  • Cure Breast Cancer Foundation
    Intellectual Property Rights
  • ECOG-ACRIN Cancer Research Group
    Professional Services and Activities (Uncompensated)
  • Genome Quebec
    Professional Services and Activities
  • Goldman Sachs
    Professional Services and Activities
  • Jubilant Therapeutics Inc.
    Professional Services and Activities
  • Kurome Therapeutics, Inc.
    Equity; Professional Services and Activities
  • Mission Bio
    Equity; Professional Services and Activities
  • Prelude Therapeutics
    Equity; Professional Services and Activities (Uncompensated)
  • Qiagen
    Equity; Fiduciary Role / Position
  • Scorpion Therapeutics, Inc.
    Equity; Professional Services and Activities
  • Stelexis Therapeutics, LLC
    Equity; Professional Services and Activities (Uncompensated)
  • Syndax
    Equity
  • The Mark Foundation for Cancer Research
    Fiduciary Role / Position; Professional Services and Activities
  • Zentalis Pharmaceuticals
    Equity; Professional Services and Activities (Uncompensated)

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures

Related topics: